Gudmundur Johannsson
Gudmundur Johannsson
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg
Verified email at gu.se
Title
Cited by
Cited by
Year
Treatment of acromegaly with the growth hormone–receptor antagonist pegvisomant
PJ Trainer, WM Drake, L Katznelson, PU Freda, V Herman-Bonert, ...
New England Journal of Medicine 342 (16), 1171-1177, 2000
9102000
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AJ van der Lely, RK Hutson, PJ Trainer, GM Besser, AL Barkan, ...
The Lancet 358 (9295), 1754-1759, 2001
7052001
Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth …
PE Clayton, S Cianfarani, P Czernichow, G Johannsson, R Rapaport, ...
The Journal of Clinical Endocrinology & Metabolism 92 (3), 804-810, 2007
6502007
Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure
G Johannsson, P Mårin, L Lönn, M Ottosson, K Stenlöf, P Björntorp, ...
The Journal of Clinical Endocrinology & Metabolism 82 (3), 727-734, 1997
5471997
Estrogen regulation of growth hormone action
KC Leung, G Johannsson, GM Leong, KKY Ho
Endocrine reviews 25 (5), 693-721, 2004
4642004
Premature mortality in patients with Addison’s disease: a population-based study
R Bergthorsdottir, M Leonsson-Zachrisson, A Odén, G Johannsson
The Journal of Clinical Endocrinology & Metabolism 91 (12), 4849-4853, 2006
4632006
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for …
KK Ho
European Journal of Endocrinology 157 (6), 695-700, 2007
4292007
The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients
H Filipsson, JP Monson, M Koltowska-Häggström, A Mattsson, ...
The Journal of Clinical Endocrinology & Metabolism 91 (10), 3954-3961, 2006
2872006
Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency
G Johannsson, T Rosen, I Bosaeus, L Sjöström, BÅ Bengtsson
The Journal of Clinical Endocrinology & Metabolism 81 (8), 2865-2873, 1996
2861996
Role of the GH/IGF-1 axis in lifespan and healthspan: lessons from animal models
DE Berryman, JS Christiansen, G Johannsson, MO Thorner, JJ Kopchick
Growth Hormone & IGF Research 18 (6), 455-471, 2008
2702008
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation
G Johannsson, AG Nilsson, R Bergthorsdottir, P Burman, P Dahlqvist, ...
The Journal of Clinical Endocrinology & Metabolism 97 (2), 473-481, 2012
2612012
Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy
J Svensson, BA Bengtsson, T Rosen, A Oden, G Johannsson
The Journal of Clinical Endocrinology & Metabolism 89 (7), 3306-3312, 2004
2462004
The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.
G Johannsson, R Bjarnason, M Bramnert, LM Carlsson, M Degerblad, ...
The Journal of Clinical Endocrinology & Metabolism 81 (4), 1575-1581, 1996
2301996
Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome
CL Deal, M Tony, C Höybye, DB Allen, M Tauber, JS Christiansen, ...
The Journal of Clinical Endocrinology & Metabolism 98 (6), E1072-E1087, 2013
2132013
Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial
G Johannsson, P Burman, L Wirén, BE Engström, AG Nilsson, ...
The Journal of Clinical Endocrinology & Metabolism 87 (5), 2046-2052, 2002
2042002
Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults
G Johannsson, T Rosén, BÅ Bengtsson
Clinical Endocrinology 47 (5), 571-581, 1997
1971997
Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults
G Johannsson, G Grimby, KS Sunnerhagen, BA Bengtsson
The Journal of Clinical Endocrinology & Metabolism 82 (9), 2877-2884, 1997
1911997
Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects
G Johannsson, K Albertsson-Wikland, ...
The Journal of Clinical Endocrinology & Metabolism 84 (12), 4516-4524, 1999
1851999
A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices
G Gotherstrom, J Svensson, J Koranyi, M Alpsten, I Bosaeus, ...
The Journal of Clinical Endocrinology & Metabolism 86 (10), 4657-4665, 2001
1752001
Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial
C Franco, J Brandberg, L Lönn, B Andersson, BA Bengtsson, ...
The Journal of Clinical Endocrinology & Metabolism 90 (3), 1466-1474, 2005
1642005
The system can't perform the operation now. Try again later.
Articles 1–20